2021-01-11,Turning Point Therapeutics Announces 2021 Milestone Targets
2021-01-11,Turning Point and Zai Lab Broaden Collaboration
2021-01-11,Turning Point and Zai Lab Broaden Collaboration
2020-12-08,"Benzinga's Top Upgrades, Downgrades For December 8, 2020"
2020-12-08,Turning Point Therapeutics Granted FDA Breakthrough Therapy Designation for Repotrectinib Treatment in Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer Who Have Not Been Treated with a ROS1 Tyrosine Kinase Inhibitor
2020-11-29,Top 10 Healthcare Stocks To Buy for the Future
2020-11-12,"Turning Point Therapeutics Reports Third-Quarter Financial Results, Provides Operational Updates"
2020-11-10,Turning Point Therapeutics to Participate in Jefferies Virtual London Healthcare Conference
2020-11-10,We're Interested To See How Turning Point Therapeutics (NASDAQ:TPTX) Uses Its Cash Hoard To Grow
2020-10-29,Turning Point Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock
2020-10-26,Turning Point Therapeutics Announces Pricing of $400 Million Public Offering of Common Stock
2020-10-26,Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock
2020-10-24,Turning Point Therapeutics Presents Initial Clinical Data From Phase 1 SHIELD-1 Study of Novel MET/SRC/CSF1R Inhibitor TPX-0022 at 2020 EORTC-NCI-AACR Symposium
2020-10-24,Cancer Meeting Could Ignite These Biotech Stocks
2020-10-22,Turning Point Therapeutics to Host Conference Call to Discuss Presentations at 2020 EORTC-NCI-AACR Virtual Symposium
2020-10-21,Turning Point Therapeutics Announces Abstract For TRIDENT-1 Clinical Study of Repotrectinib Accepted For Presentation at World Conference on Lung Cancer
2020-10-07,Turning Point Therapeutics Announces Early Clinical Data For Novel MET Inhibitor TPX-0022 Selected For Late-Breaker Oral Presentation at 32nd EORTC-NCI-AACR Symposium
2020-09-30,Turning Point Therapeutics to Participate in Upcoming Virtual Investor Conference
2020-09-21,Turning Point Therapeutics to Participate in H.C. Wainwright Precision Oncology Investor Conference
2020-09-16,"Hedge Funds Turning More Bullish On Turning Point Therapeutics, Inc. (TPTX)"
2020-09-01,Turning Point Therapeutics to Participate in Upcoming Investor Conferences
2020-08-31,Turning Point Therapeutics Announces Scientific Advisory Board
2020-08-24,Turning Point Therapeutics Granted Fast-Track Designation for Repotrectinib in NTRK-Positive TKI-Pretreated Advanced Solid Tumors
2020-08-21,A Big Boost in Earnings Estimates for Nvidia
2020-08-20,Turning Point Therapeutics (TPTX) Looks Good: Stock Adds 5.3% in Session
2020-08-19,"Turning Point Therapeutics Reports Early Interim Data From Registrational Phase 2 Trident-1 Study of Repotrectinib, Provides Regulatory Update"
2020-08-10,"Turning Point Therapeutics (TPTX) Reports Q2 Loss, Lags Revenue Estimates"
2020-08-10,"Turning Point Therapeutics Reports Second-Quarter Financial Results, Provides Operational Updates"
2020-08-04,"Did Hedge Funds Make The Right Call On Turning Point Therapeutics, Inc. (TPTX) ?"
2020-07-27,Turning Point Therapeutics Names Heather Adams as Vice President of Human Resources
2020-07-13,Turning Point Therapeutics Names Andrew Partridge As Executive Vice President and Chief Commercial Officer
2020-07-07,Turning Point Therapeutics Licenses Its Lung Cancer Drug in China
2020-07-07,Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement For Repotrectinib in Greater China
2020-06-22,Turning Point Therapeutics Lead Drug Candidate Repotrectinib Increases Effectiveness of KRAS-G12C and MEK Inhibitors in Preclincal KRAS Cancer Models
2020-06-01,Turning Point Therapeutics to Participate in Goldman Sachs 41st Annual Global Healthcare Conference Webcast
2020-05-29,"Turning Point Therapeutics Presents Preclinical Data For Novel RET Inhibitor Candidate, TPX-0046"
2020-05-28,"Trade Alert: The President Of Turning Point Therapeutics, Inc. (NASDAQ:TPTX), Athena Countouriotis, Has Just Spent US$250k Buying 18% More Shares"
2020-05-27,Turning Point Therapeutics Announces Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock
2020-05-18,Turning Point Therapeutics Announces Pricing of $325 Million Public Offering of Common Stock
2020-05-18,Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock
2020-05-12,Turning Point Therapeutics Inc (TPTX) Q1 2020 Earnings Call Transcript
2020-05-12,"Turning Point Therapeutics Reports First-Quarter Financial Results, Provides Update on Operations and COVID-19 Response"
2020-05-11,"Biotech Stock Q1 Earnings Due on May 12: ADPT, VIR, TPTX"
2020-05-04,Turning Point Therapeutics to Host First Quarter Conference Call
2020-04-16,Clinical Cancer Research Highlights Potent Antitumor Activity of Repotrectinib in Treatment-Naïve and Solvent-Front Mutation Ros1-Positive Non-Small Cell Lung Cancer
2020-04-09,Turning Point Therapeutics (NASDAQ:TPTX) Is In A Good Position To Deliver On Growth Plans
2020-04-08,"Hedge Funds Have Never Been This Bullish On Turning Point Therapeutics, Inc. (TPTX)"
2020-04-08,Will Turning Point Therapeutics Continue to Surge Higher?
2020-03-24,Is Turning Point Therapeutics (TPTX) Stock a Solid Choice Right Now?
2020-03-18,"Turning Point Therapeutics, Inc. to Host Earnings Call"
2020-03-16,"TURNING POINT THERAPEUTICS REPORTS FOURTH-QUARTER, FULL- YEAR 2019 FINANCIAL AND OPERATIONAL RESULTS"
2020-03-02,"Turning Point Therapeutics to Host Fourth-Quarter, Full-Year 2019 Conference Call"
2020-02-20,Turning Point Therapeutics Names Siegfried Reich as Executive Vice President and Chief Scientific Officer
2020-02-18,Turning Point Therapeutics to Participate in Upcoming Investor Conferences
2020-02-03,Turning Point Therapeutics to Participate in Guggenheim Oncology Day
2020-01-23,Turning Point Therapeutics Names Garry Nicholson to Its Board of Directors
2020-01-13,Turning Point Therapeutics Announces Program Updates and Milestones for 2020
2020-01-10,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx"
2020-01-09,Turning Point Therapeutics Announces Management Transition
2020-01-09,"Are Insiders Buying Turning Point Therapeutics, Inc. (NASDAQ:TPTX) Stock?"
2020-01-06,"Turning Point Therapeutics Names Homa Yeganegi Senior Vice President, Project Team Leader and Head of Medical Affairs"
2019-12-27,"The Zacks Analyst Blog Highlights: BYND, ZM, KRTX, TPTX and SILK"
2019-12-26,5 Best Performing IPOs of 2019
2019-12-23,"Hedge Funds Have Never Been This Bullish On Turning Point Therapeutics, Inc. (TPTX)"
2019-12-17,Turning Point Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare Conference
2019-12-10,Turning Point (TPTX) Catches Eye: Stock Jumps 6.1%
2019-11-19,Weighing the Risk-Reward in Turning Point Therapeutics
2019-11-13,Turning Point Therapeutics to Participate in Upcoming Investor Conferences
2019-11-12,Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of Repotrectinib in Pediatric Patients
2019-11-11,"Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of TPX-0046, a Novel RET/SRC Inhibitor"
2019-11-08,"The Zacks Analyst Blog Highlights: Zoom Video Communications, Beyond Meat, Turning Point Therapeutics and Cortexyme"
2019-11-07,4 Best-Performing IPOs So Far in 2019
2019-11-04,Turning Point Therapeutics Reports Third Quarter 2019 Financial and Operational Results
2019-10-28,"Hedge Funds Have Never Been This Bullish On Turning Point Therapeutics, Inc. (TPTX)"
2019-10-21,Turning Point Therapeutics to Host Third Quarter 2019 Conference Call
2019-09-30,"Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0046, a Novel RET/SRC Inhibitor"
2019-09-18,Is Failure in Store for the WeWork IPO?
2019-09-11,"Turning Point Therapeutics Inc (TPTX) President & CEO Athena Countouriotis Bought $450,000 ..."
2019-09-09,Short Squeeze Candidates: 10 Most Heavily Shorted Stocks
2019-09-05,Turning Point Therapeutics Announces Pricing of Public Offering of Common Stock
2019-09-03,Turning Point Therapeutics Announces Proposed Public Offering of Common Stock
2019-09-03,"Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib and Preclinical Data for TPX-0046, a Novel RET/SRC Inhibitor"
2019-08-29,3 New Biotech Stocks That Keep On Soaring
2019-08-28,Turning Point Therapeutics Participate in Upcoming Investor Conferences
2019-08-06,Turning Point Therapeutics Reports Second Quarter 2019 Financial and Operational Results
2019-08-01,"What Kind Of Shareholder Appears On The Turning Point Therapeutics, Inc.'s (NASDAQ:TPTX) Shareholder Register?"
2019-07-31,Turning Point Therapeutics CEO to Present at Canaccord Genuity 39th Annual Growth Conference
2019-07-31,"Turning Point Therapeutics Initiates Phase 1 Clinical Study of Tpx-0022, a Novel Met Inhibitor Targeting Advanced Solid Tumors"
2019-07-29,Turning Point Therapeutics Appoints Biotechnology Investment Banker Yi Larson as Executive Vice President and Chief Financial Officer
2019-07-25,"Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors"
2019-07-22,Turning Point Therapeutics to Host Second Quarter 2019 Conference Call
2019-06-20,Turning Point Therapeutics Initiates Phase 2 Registrational Portion of TRIDENT-1 Clinical Study
2019-06-18,Shares of cancer-therapy companies skyrocket after Pfizer acquisition news
2019-06-04,Turning Point Therapeutics CEO to Present at Goldman Sachs 40th Annual Global Healthcare Conference
2019-05-31,Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib in Advanced ROS1+ Non-Small Cell Lung Cancer
2019-05-24,Bay Area figures prominently in hottest IPOs so far this year
2019-05-15,"Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0022, a Novel MET/CSF1R/SRC Inhibitor"
2019-05-14,Turning Point Therapeutics' CEO to Present at UBS Healthcare Conference
2019-05-14,"Turning Point Therapeutics Names Biotech Veteran Patrick Machado, J.D. to Its Board of Directors"
2019-05-06,Turning Point Therapeutics and Almac Diagnostic Services Announce Approval of an Investigational Device Exemption for the Companion Diagnostic Assay to the Registrational TRIDENT-1 Clinical Study
